CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: August 15, 2019
Result type: Reports
Product Line: Common Drug Review

Generic Name: tezacaftor/ivacaftor

Brand Name: Symdeko

Manufacturer: Vertex Pharmaceuticals Canada Inc.

Indications: Cystic fibrosis, F508del mutation(s)

Submission Type: Non-submission

Project Status: Not filed

Recommendation Type: CADTH is unable to recommend reimbursement as a submission was not filed by the manufacturer